Anti-human Integrin a2b3 (Tadocizumab Biosimilar) NKAT10 and murine studies suggest a

and murine studies suggest a role in tumor-associated tissue remodeling

Conjugation None Clone# Basiliximab Formulation 100 mM Pro-Ac 20mM Arg pH 5

Number Component 50T Concentration Storage 1 PBS Buffer (powder) 2L x 2 20x RT 2 Antigen Retrieval Buffer 20ml 100x 2-8°C 3 Endogenous Peroxidase Blocking Buffer 3ml RTU 2-8°C 4 Blocking Buffer 3ml RTU 2-8°C 5 Primary Antibody (Rat NeuN Recombinant Rabbit mAb) 6ml RTU 2-8°C 6 Secondary Antibody (HRP-Goat anti-Rabbit IgG pAb) 6ml RTU 2-8°C 7 Chromogen Component A 0

Catalog# BIO0781SM Product Name Anti-human Tenascin C (Tenatumomab Biosimilar) Specifications

and operation in complete darkness is unnecessary

Anti-human Integrin a2b3 (Tadocizumab Biosimilar) NKAT10 and murine studies suggest aApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name Integrin a2b3 Target Uniprot P17301 & P05106 Overview Catalog# BIO0776SM Product Name Anti human Integrin a2b3 (Tadocizumab Biosimilar) Specifications Conjugation None Clone# Tadocizumab Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with sterile